Skip to main content

Spastic Paraplegia 2

OMIM ID:

X-linked recessive

Spastic Paraplegia 2

Alternate Names

X-linked spastic paraplegia
SPG2
SPPX2

Defective Genes

PLP1

Clinical Characteristics

Ocular Features

Nystagmus is common but variable in age of onset, and half of affected individuals have optic atrophy.

Systemic Features

This is a complex form of spastic paraplegia in which primarily lower limb spasticity is associated with dysarthria, sensory disturbances, cognitive deficits, muscle wasting and mild ataxia.  There is, however, considerable variability in age of onset and rate of symptom progression.  The first motor symptoms are often evident when children start walking, which is often delayed and clumsy.  However, evidence of spasticity may be present in children under 1 year of age.   Some patients have normal mental functions while others are considered mentally retarded.  The MRI reveals patchy leukodystrophy and degeneration of both corticospinal and spinocerebellar tracks was found in an autopsied individual.  Progression is relentless with many individuals requiring assistive devices such as crutches or walkers by early adult life.

Genetics

Inheritance

This is an X-linked disorder secondary to a mutation in the PLP1 gene at Xq22.2which codes for 2 major proteins found in myelin.  SPG2 is allelic to the more severe Pelizaeus-Merzbacher disease (312080).

Treatment & Management

Mobility devices and physical therapy can be helpful, especially in younger individuals.

Selected Resources

Publications

Displaying 1 - 2 of 2

PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2

PubMedID: 15627202

X‐linked spastic paraplegia: evidence for homogeneity with a variable phenotype

PubMedID: 2470540